More than 1,800 employees at the Bern facility develop and manufacture innovative biotherapies derived from human plasma.
CSL Behring in Lengnau: Thermo Fisher Scientific and CSL enter strategic partnership
We are proud to work in the field of rare and serious diseases and to provide therapy in many areas of treatment.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people's health.
Every day at CSL Behring, we work as if someone's life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver our promise to save lives and protect the health of people.
Grow with us: CSL Behring offers university graduates an interesting career as a trainee.
Popular search terms:
News from our Protinus Project
Women in Digital: Learn more from CSL experts in the webinar on 9 June.
We at CSL Behring AG in Bern are proud of our neighbor and partner BSC Young Boys.
To strengthen its R&D foothold in the Romandy, CSL opens a permanent R&D office in one of the most thriving biotech hubs in S…
The three winners were honored at the graduation ceremony of the University of Bern. (Pictures: Adrian Moser)
BSC Young Boys warmly welcomed Paul McKenzie, CSL's new CEO and Managing Director.
On 28 February 2023 Rare Disease Day will be taking place. #seerare
CSL reported net income after tax of $1.62 billion in the first half of 2023.
The fully automated visual system allows vials to be checked three times faster than the previous process.
CSL scientists are collaborating with research partners in Bern to investigate the biological indicators of sickle cell disea…
Americas
Asia Pacific
Middle East
Europe
